BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1935216)

  • 1. Glucagonoma syndrome.
    van Hecke E; Geerts ML; Kint A; Debersaques J; Naeyaert JM
    Curr Probl Dermatol; 1991; 20():24-33. PubMed ID: 1935216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Facial erythema and pancreatic glucagonoma].
    Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
    Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagonoma and necrolytic migratory erythema.
    Echenique-Elizondo M; Martínez de Lizarduy I
    Rev Esp Enferm Dig; 2005 Jun; 97(6):455-7. PubMed ID: 16011420
    [No Abstract]   [Full Text] [Related]  

  • 4. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient with long-standing skin lesions. Necrolytic migratory erythema.
    Netea RT; Erceg A; Pieters G; Hermus AR
    Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
    Johnson SM; Smoller BR; Lamps LW; Horn TD
    J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucagonoma syndrome: diagnosis and treatment.
    Zeng J; Wang B; Ma D; Li F
    J Am Acad Dermatol; 2003 Feb; 48(2):297-8. PubMed ID: 12582409
    [No Abstract]   [Full Text] [Related]  

  • 12. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 13. Necrolytic migratory erythema associated with glucagonoma: a report of 2 cases.
    Teixeira RC; Nico MM; Ghideti AC
    Clinics (Sao Paulo); 2008 Apr; 63(2):267-70. PubMed ID: 18438582
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic glucagonoma presenting as necrolytic migratory erythema.
    Colombo E; Zuccoli R; Ugolini M; Dardano F; Leigheb G
    J Clin Oncol; 2007 May; 25(15):2135-6. PubMed ID: 17513822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucagonoma syndrome. Unusual histologic image].
    Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
    Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
    [No Abstract]   [Full Text] [Related]  

  • 16. The glucagonoma syndrome--report of a case without overt diabetes.
    Leibovici V; Granot E; Eid A; Goldin E; Okon E
    J Dermatol; 1987 Oct; 14(5):491-6. PubMed ID: 2830323
    [No Abstract]   [Full Text] [Related]  

  • 17. A glucagonoma without necrolytic migratory erythema.
    Davies JP; Billings PJ; Aubrey DA
    Pancreas; 1992; 7(3):398-400. PubMed ID: 1594565
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
    Ditty JF; Lang PG
    South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
    Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
    J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.